Best Vitamin infusions doctors: TOP 59 doctors

In 1981 he graduated from the Faculty of Medicine and Surgery of the University of Barcelona.

Specialist in medical-surgical dermatology and venereology MIR at the Hospital del Sagrado Corazon in Barcelona in 1987.

After completing his specialty, he worked as a doctor at the Hospital del Sagrado Corazón in Barcelona until 1993, where he gained experience in dermatological surgery and laser therapy.

In 1994, he founded the Dermatology Department of the Teknon Medical Center, where he is currently a prominent collaborator and Medical Director. Over the years, he has created and consolidated a team of professionals with a wide range of specialties in clinical dermatology, aesthetics, oncology and laser therapy. In addition to coordinating training groups for dermatology doctors.

In 2014, he founded the DermAndTek clinic in Andorra with the aim of providing comprehensive services in clinical and aesthetic dermatology using the latest technologies in laser therapy, prevention and treatment of skin cancer.

The Dr. López Gil Dermatology Clinic is a team of dermatologists from the Quiróns Teknon Hospital in Barcelona, specialising in various areas of clinical dermatology, aesthetic dermatology, laser treatments, hair treatments and the latest medical technologies.

Their specializations:

- Clinical dermatology

- Aesthetic dermatology

- Oncological dermatology

- Hair loss

- Laser therapy

- Excessive sweating and hyperhidrosis

- Venereal diseases

Published journal articles indexed by SCI, SSCI, and AHCI I. Investigation of the effectiveness of teledermatology in the diagnosis of skin lesions in pediatric patients TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),vol.69,no.10,2023 (SCI-Expanded) I . Can a Correct Diagnosis Be Established Using the TeledermatologyMethod? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,vol.30,no.1,pp.32-39,2022 (SCI-Expanded) I I. Melkersson-Rosenthal syndrome induced by COVID-19: A case report TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine,vol.41,2021 (SCI-Expanded) IV. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them? CENGİZ F.P.,EMİROĞLUN.,BAHALIA.G.,DİZMAND.,TAŞLIDEREN.,AkarslanT.C.,GunesB.,MERTÖ.,KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY,vol.33,no.4,2020 (SCI-Expanded)

Areas of activity: • Research of pathology in gerontological age group (elderly) patients • Clinical nutrition (enteral and parenteral nutrition) • Diabetes mellitus, metabolic syndrome, osteoporosis, thyroid diseases • Arterial hypertension • High body temperature of unknown genesis (fever) • Diseases of the musculoskeletal system, rheumatological diseases • Diseases of the gastrointestinal tract, liver • Disorders of water and electrolyte metabolism, kidney diseases Education: • Higher education - Azerbaijan Medical University, Faculty of General Medicine and Prevention, 2008-2014 • Specialization – Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine Work experience: • Baku State Hospital No. 3, resident physician nephrologist. 2014-2016 • Istanbul Private Bahcelievler Memorial Hospital, specialist in internal medicine. 2021-2022 Research work: (dissertation / defense) • Clinical and laboratory features of patients with acute interstitial nephritis diagnosed during kidney biopsy, factors influencing the etiology and response to treatment. Istanbul University, Istanbul Faculty of Medicine, Department of Nephrology, 2021 Publications:(2) •P343Efficacy of adalimumab mild-to-moderate inflammatory bowel disease: Real-life data from a single-centre experience in the long-term period. January 2020 Journal of Crohns and Colitis DOI: 10.1093/ecco-jcc/jjz203.472 •Concurrent myelomatous pleural effusion and extramedullary mediastinalinvolvement as a relapse manifestation of multiple myeloma. Abstract of the IXth International Eurasian Hematology OncologyCongress17–20October2018Istanbul,Turkey(Concomitant myelomatous pleurisy and extramedullary mediastinal lesion as a recurrent manifestation of multiple myeloma. Abstracts of the IX International Eurasian Oncohematology Congress17–20October2018Istanbul,Türkiye) Memberships in scientific organizations: •Turkish Medical Association

I was born in Naples, born in 1981, and I have the best job in the world. Imagine waking up every morning and knowing that on that day you will make someone's dream come true: you will change a man's life forever, you will give birth to a new woman, you will help a girl achieve happiness, a boy gain self-confidence. I am Silvio Ascione, specialist in Plastic, Reconstructive and Aesthetic Surgery. Son of art, from my father, a great man and great plastic surgeon, I learned the complex and enchanting magic of aesthetic plastic surgery. Nourished by art and medical knowledge, I grew up in operating theatres, always behind my father's back who, like the best of masters, passed on to me, a young disciple, the passion for a profession in which art combines to science to create masterpieces. Graduated in Medicine and Surgery in 2005 from the Second University of Naples, qualified in the first session of 2006 and specialized in Plastic, Reconstructive and Aesthetic Surgery at the School of Specialization of the Second University of Naples directed by Prof. Francesco D'Andrea, I am enrolled in the 'Order of Surgeons of Benevento and I obtained a Master's degree in Oncoplastic Surgery and integrated treatments at the University of Genoa.

My experience in the surgical room, however, began much earlier, and it was an intense, very hard journey, characterized by total dedication, constant updating, continuous training: initially internal at the Department of Plastic, Reconstructive and Aesthetic Surgery of the S.U.N., I frequented then the Department of Reconstructive and Aesthetic Plastic Surgery of the Mediterranean Clinic of Naples affiliated with the “Tor Vergata” University of Rome, the A.O.R.N. Major Burns Center Department, directed by Prof. Roberto D'Alessio, the Trauma Center Department of Prof. Antonio Martin.

I regularly participate in all the main national and international Plastic Surgery conferences to stay constantly updated on the technological innovations offered by the market, the cutting-edge products and instruments to be used for my treatments, the new research and the most recent studies in the field of plastic and aesthetic surgery.

I studied and carried out in-depth internships at universities and hospital centers in Spain, France and North America, gaining extraordinary experience on the most advanced surgical techniques, in particular on facial and breast rejuvenation.

​

MY MISSION

My innate passion for surgery, my attention to the care of the image and the harmony of forms, my obsessive precision and attention to detail, my unstoppable research and updating activity, my decades of experience in the most varied spheres of plastic and aesthetic surgery, working side by side with my specialized team, allow me today to boast a curriculum full of successes and satisfactions and to be able to offer my patients a detailed and scrupulous visit, a precise diagnosis, a treatment plan personalized and efficient intervention, agreed on the basis of the patient's needs and desires, highly effective personal techniques and tools to eliminate all types of blemishes, signs of aging or congenital imperfections, through increasingly less invasive interventions and with increasingly natural results.

​

Experience, professionalism, harmony, naturalness: these are the four key points on which I build a relationship that is first human, then professional, with my patient. The choice of plastic or aesthetic surgery does not only involve the decision to undertake a path of external change. For this reason I dedicate myself with dedication and attention to listening to the discomforts and wishes of each of my patients, so that we can plan together the most appropriate intervention for their needs and to achieve the expected result and to accompany them step by step towards a path of external and internal rebirth

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Professional Experience:

2017 - 2024: SALTAT CLINIC GÖZTEPE BRANCH, Specialist in Dermatology and Venereology

2014 - 2017: MEMORIAL WELLNESS, Specialist in Dermatology and Venereology

2008 - 2014: PRIVATE ISTANBUL MEDIPOL HOSPITAL, Specialist in Dermatology and Venereology

2006 - 2008: MEDICALPARK BAHÇELİEVLER HOSPITAL, Specialist in Dermatology and Venereology

2003 - 2006: TBV SERVICE HOSPITAL, Specialist in Dermatology and Venereology

1999 - 2003: FIZIKOM AESTHETICS AND LASER CENTER, Specialist in Dermatology and Venereology

Education:

1996 - 1999: HASEKI STATE HOSPITAL - Residency in Dermatology

1989 - 1995: ISTANBUL UNIVERSITY, ISTANBUL FACULTY OF MEDICINE, Medical Doctor Training

General Practitioner/ Medical Director
certified by American Academy of Anti-Aging Medicine

A credentialed physician, general practitioner, MD has gained valuable

diverse experience and a special interest in Aesthetic Medicine. Dr. Farshad is a

certified member of the American Academy of Anti-Aging Medicine (A4M),

certified in advanced injectables and laser therapy  by the National Council on Laser Certification (NCLC) USA.
 

Dr. Farshad comes from a family of medical practitioners. In 1998, he graduated from Shiraz (Pahlavi) University of Medical Sciences. Since then, having great career achievements in Family Medicine across Canada and UAE, he pursued gaining knowledge and practice in aesthetics. Following his passion he performs with a holistic and professional approach to - as he calls it - “Feel-Good procedures” to turn back the hands of time and help his patients, to meet their desire in looking young, fresh and rejuvenated.

Doctor Farshad is mastered in a myriad of aesthetic procedures including Botox and Dermal filler injections, non-surgical facelift advanced methods and various laser Treatments and Laser Therapy. His vast international and multicultural experience allows him the understanding and balance of East and West when caring and treating patients from all backgrounds and ethnicities.

Besides extensive experience, his obsession with details and unrivalled precision for creating the most outstanding natural results has made him to be able to combine the vision of Art and Aesthetics with the most advanced medical treatments to enhance the natural beauty of each individual.
 

Key International Publication
Kim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.
“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”
Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.

International Conference Presentations

The International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, Korea

The 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, Thailand

Domestic Conference Presentations

The Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, Korea

The 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, Korea

The 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, Korea

The 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, Korea

The Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea

Education and Specialization

• 2004/2010: Fırat University Faculty of Medicine
• 2012/2017: Uludağ University Faculty of Medicine – Specialization

Experience

• 2017/2021: Ankara Training and Research Hospital
• 2021/2023: Kilis State Hospital
• 2023/2024: Private Gaziantep Emek Hospital

Professional Memberships

• Aesthetic and Cosmetic Dermatology Society (Estetik ve Kozmetik Dermatoloji Derneği)
• Turkish Dermatology Society (Türk Dermatoloji Derneği)
• Turkish Medical Association (Türk Tabipler Birliği)

Dr. Sarassawadee is a highly skilled medical physician with extensive expertise in aesthetic medicine, regenerative therapies, and IV nutrition therapy. With a strong foundation in both general medicine and advanced anti-aging treatments, she is dedicated to providing cutting-edge, science-backed solutions for wellness, longevity, and skin rejuvenation.

Education & Medical Training:

✅Medical Physician – Sarassawadee

✅Internship Training at Police General Hospital

✅Internship Training at Ananda Mahidol Hospital

Professional Certifications & Specializations:

✅ Certificate in Aesthetic Medicine – American Academy of Aesthetic Medicine (AAAM)

✅ Member of the American Academy of Aesthetic Medicine (AAAM)

✅ Certificate of Attendance: Sculptra Training

✅ Certificate in IV Nutrition Infusion Therapy – Canadian Board of Aesthetic Medicine (CBAM)

✅ Certificate in Allogeneic Cellular Therapy for Regenerative Medicine – International Society for Stem Cell Application (ISSCA)

✅ Certificate of Attendance – HEAT International Congress on Wellness Management

✅ Nutraceutical Certificate – Department of Thai Traditional and Complementary Medicine

With her extensive knowledge and international certifications, Dr. Sarassawadee is at the forefront of anti-aging medicine, regenerative therapies, and aesthetic procedures, offering personalized treatments that enhance health, beauty, and longevity.

Education Background "Dr.Wariya Charoenrakdee" (Dr.Koy)

-Medical Degree of Navamindradhiraj University

-Master degree of Science of Dhurakij Pandit University (Anti-Aging regenerative medicine)

-Board certified of American Board of Anti-aging and Regenerative Medicine

-Certification of Aesthetic Training Program, Aesthetic Academy.

-Certification of Stem cell for Aesthetic, HEAT

-Certification of Chelation Therapy, Chelation Medical Association,Thai.

- Doctor of Medicine, Nawamintharachiraj University

-Master of Science in Anti-Aging and Regenerative Science, Dhurakij Pundit University

Rejuvenate Beauty with Konarc Aesthetics Cosmetic Surgery in Gurgaon, India

For those battling with insecurities about their appearance, cosmetic surgery offers a transformative solution. Dr. Preeti Yadav at Konarc Aesthetics, a seasoned plastic surgeon with over a decade of experience in aesthetics, leads a renowned clinic in Gurgaon, India. Her approach is holistic, catering to each patient's unique needs and desires.

As a female plastic surgeon, Dr. Preeti Yadav understands the specific concerns that women face regarding their bodies. From mothers seeking post-childbirth recovery to teenagers grappling with body image issues, Dr. Yadav empathetically listens to her patients' worries and provides sustainable solutions.

The clinic specializes in a range of procedures tailored to enhance beauty and confidence. Popular treatments include rhinoplasty, jawline shaping, chin enhancement, cheek augmentation, lip fillers, arm and back liposuction, bust surgeries (reduction/enlargement/lift), tummy and waist sculpting, buttock lifts, vaginal rejuvenation, and thigh lifts.

Treatments and Procedures

• Hair Transplant
• Liposuction
• Breast reshaping
• Facial plastic surgery
• Laser therapy
• Male breast surgery
• Reconstructive surgery
• Surgical and non-surgical weight loss procedures
• Non-surgical treatments like botox and fillers

More Information you can contact to us.

Education Background “Dr. Tanaporn Eiamprapai” (Dr.Ploy)

-Medical Degree, Phramongkutklao College of Medicine, Mahidol University

-Master of Science in Clinical Dermatology, Cardiff University

-Board certified of American Board of Anti-Aging and Regenerative Medicine

-Certification of Aesthetic Training Program, Aesthetic Academy.

-Certification of Stem cell for Aesthetic, HEAT

-Certification of Chelation Therapy, Chelation Medical Association,Thai.

-Bachelor of Medicine, Mongkut's Institute of Technology Ladkrabang, Mahidol University

- Master of Science in Dermatology, Cardiff University, United Kingdom

Dr. First Hunsajarupan is a medical physician specializing in aesthetic medicine and dermatology, with a strong background in clinical practice, advanced aesthetic procedures, and regenerative medicine. With international training and certifications, Dr. First is dedicated to delivering cutting-edge treatments to enhance skin health, anti-aging, and wellness.

Education & Medical Training:

✅ MSc. Dermatology – CICM, Thammasat University Hospital

✅ Doctor of Medicine (M.D.) – Faculty of Medicine, Thammasat University

✅ Internship – Ananda Mahidol Hospital, Lopburi

✅ General Practitioner – Royal Thai Army Medical Department

✅ Dermatology outpatient department – Benchakitti Park Hospital

Professional Certifications & Specializations:

✅ Certificate in Aesthetic Medicine – American Academy of Aesthetic Medicine (AAAM)

✅ Member of the American Academy of Aesthetic Medicine (AAAM)

✅ Certificate of Participation Practical Cell Therapy Symposium

✅ HEAT International Congress Wellness Management

✅ Certificate of Participation American Board of Laser Surgery

✅ Certificate of Participation Vaginal Rejuvenation

✅ Integrative Botulinum Injection for Upper & Lower Face – Rassapoom Medical Institute

✅ Nutraceutical Certificate – Department of Thai Traditional and Complementary Medicine

Dr. Napat combines evidence-based medical knowledge with aesthetic innovations to deliver personalized skin care and anti-aging treatments. With a commitment to ongoing professional development, Dr. First continuously integrates the latest rejuvenation techniques to achieve optimal patient results.

Educational Background "Dr.Nathamon Gunmintr" (Dr.Now)

-Medical Degree, Siriraj hospital (1st class honor)

-Master of Science in Clinical Dermatology, Cardiff University (Distinction)

-Currently studying PhD Anti-aging and Regenerative medicine DPU

-Certification of Aesthetic Training Program, Aesthetic Academy.

-Certification of Stem cell for Aesthetic, HEAT

-Certification of Chelation Therapy, Chelation Medical Association,Thai.

-Bachelor of Medicine, Siriraj Hospital (First Class Honors)

-Master of Dermatology, University of Cardiff, UK

-Currently studying for a PhD in Anti-Aging and Regenerative Medicine at Dhurakij Pundit University

Education Background "Dr.Thanyalak Gaeosuksai" (Dr.Thanya)

-Advance Nutrition for Wellness Program, Integrative Functional Nutrition and Wellness Center, Bangkok Thailand 

-ANTI-AGING FELLOWSHIP Dhurakit Pundit University , Bangkok Thailand

-BACHELOR OF MEDICINE AND BACHELOR OF SURGERY (MBBS) Zhengzhou University, Zhengzhou, Henan, P.R.C 

-HEAT congress Participant 

-A4M Symposium Attendee 

-Stem cells for Aesthetics

• Specialize on Hair Transplantation with DHI Technique. 
• Speaker of Hansbiomed Thailand
• Instructor hair transplant tranining course for other doctor at MP Academy.
• Instructor Advanced Filler tranining course for other doctor at MP Academy.
• Founder and Director of MP Clinic
• Founder of One Bright Clinic Chiangmai
• Founder of MP Clinic Chiangmai
• Founder of Morepure Clinic Phuket
• Chief Executive Officer of MP Clinic
• Chief Financial Officer of MP Clinic
• Chief Marketing Officer of MP Clinic
• Chief Operating Officer of MP Clinic

DR. Arzu Musaeva

Education: Azerbaijan Medical University.

Specialization: therapist

Working hours and days: weekdays 10:00-15:00.

Training and membership:

16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

improvement.

01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

Germany).

12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

Baden, Germany).

20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

02/16/2010. "Homotoxicology" Dr. Alta Smith.

05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

Joachim Bandlow.

21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

"Sharing Methods" by Dr. Jurgen Frost.

07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

refresher course.

11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

(Baden-Baden, Germany).

12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

Flechsig (Germany).

10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

(Switzerland).

14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

honey. Arturo Obirne (Colombia).

15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

(Baden-Baden, Germany).

04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

Doctor med. Siddhartha Popat (Baden-Baden, Germany).

01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

Preussler (Germany).

05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

(Colombia).

Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

Received the Hans-Heinrich Reckeweg Prize for clinical cases.

Examinations and treatment performed:

• Bioregulatory therapy of all therapeutic diseases.

• Atherosclerosis, stenosis, occlusion of peripheral arteries.

• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

• Peripheral nerve neuropathy.

• Diabetic paw, osteoarthropathy, osteomyelitis.

• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

treatment and prevention of delayed complications in the lower extremities.

• Gangrenous pyoderma.

• Treatment of trophic ulcers.

Surgeon Ekrem Keskin was born in 1986 in Istanbul. He completed his education at Istanbul University Cerrahpaşa Faculty of Medicine in 2010, and was awarded the title of Medical Doctor. During his residency training he was instructed in nose, facial and breast aesthetics under the supervision of James Zins, MD and Raffi Gurunluoglu, MD, at Cleveland Clinic Plastic and Reconstructive and Aesthetic Surgery Department, Cleveland, OHIO-USA in 2016. After 5 years of Plastic, Reconstructive and Aesthetic Surgery training, he completed his specialization and became a Plastic and Aesthetic Surgery Specialist.

I graduated in 2002 from Anatolia College (the American College of Thessaloniki) with an “Excellent” overall grade and was admitted to the Medical School of the University of Thessaloniki.
In 2006, I trained at Harvard in the United States in medical research methodology and the biological behavior of cancer cells.
In 2008, I graduated from the School of Medicine at the Aristotle University of Thessaloniki (AUTH) with a “Very Good” grade.
In 2014, I was awarded the medical specialty title of Dermatology after five years of training abroad.
I am a doctoral candidate at the University of Giessen in Germany, with a dissertation topic: “Rosazea: Psychosoziale Aspekte einer entstellenden Hauterkrankung – Eine Fallkontrollstudie unter Praxisbedingungen in Vergleich zu Menschen mit Muttermalen.”

Conferences – Workshops
I stay continually up-to-date by attending Greek and international conferences and workshops on developments in clinical, interventional, and aesthetic dermatology.

I frequently participate as a trainer or speaker at the conferences of the Hellenic Dermatological and Venereological Society and the Hellenic Society of Dermatologic Surgery, Laser, and Aesthetic Dermatology in the areas where I specialize (autoimmune dermatological diseases, growth factors, dermatologic surgery, etc.).

Publications
In 2022, I published the book Rosacea (Ροδόχρους Νόσος) through iWrite Publications.

I have delivered more than 200 presentations at dermatological conferences and have authored articles in scientific journals.

I am a member of the following societies:
• German Dermatological Society (DDG)
• German Society of Dermatologic Surgery
• Hellenic Dermatological and Venereological Society (EDAE)
• Hellenic Society of Dermatologic Surgery
• Hellenic Society of Anti-Aging
• Anatolia College Alumni Association
From 2011 to 2014, I worked at the Max Planck University Clinic in Göttingen, Germany, focusing on the following areas:

• Clinical Dermatology: acne, eczema, autoimmune skin diseases (vitiligo, lupus, scleroderma, etc.), pediatric dermatology, scalp conditions, and more.
• Dermatologic Surgery: removal of skin tumors for medical and cosmetic purposes, skin grafts, blepharoplasty, chronic ulcer treatment, surgical management of hidradenitis suppurativa, and more.
• Dermato-Oncology: diagnosis and treatment of melanoma (both surgical and chemotherapeutic), management of basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, sentinel lymph node biopsy and complete lymph node dissection, etc. I also participated in a clinical trial of Vemurafenib, a drug for metastatic melanoma.
• Aesthetic Dermatology: Botox, hyaluronic acid fillers, removal of skin lesions for cosmetic purposes (surgically and with laser), varicose vein treatment with sclerotherapy and laser, and more.

I was in charge of the Outpatient Clinics for Dermato-Oncology, Aesthetic Dermatology, Venous Diseases, and Laser at the University of Göttingen, and I served as the trainer responsible for new residents.

In 2015, I worked at the Langrock & Paul Polyclinic of Dermatology, Dermatologic Surgery, and Aesthetic Dermatology in the greater Frankfurt area, concentrating on dermatologic surgery, aesthetic dermatology (treatment of expression wrinkles, blepharoplasty, hyaluronic acid fillers, mesotherapy, lipolysis, laser, etc.), and allergology.

From 2016 to 2023, I worked at the Myskin Clinic of Clinical, Aesthetic, and Interventional Dermatology in Thessaloniki and Naoussa (Imathia).

In 2024, together with my wife, Evangelia Yazitzoglou, we established the Endocrinology and Dermatology Clinic of Thessaloniki, aiming to provide a holistic and comprehensive approach to patient